financetom
Business
financetom
/
Business
/
Pitney Bowes Buys Royal Alliances' Presort Business
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pitney Bowes Buys Royal Alliances' Presort Business
Jan 21, 2025 9:17 AM

11:49 AM EST, 01/21/2025 (MT Newswires) -- Pitney Bowes ( PBI ) said Tuesday that it has acquired the presort business of Royal Alliances, strengthening the company's presort services network across the US.

Financial details weren't provided.

The deal, effective as of Monday, is set to add over 100 million First-Class Mail pieces annually to Pitney Bowes' ( PBI ) network. Royal Alliances will continue to operate its freight brokerage business under the name Direct Logistics.

Price: 7.31, Change: +0.06, Percent Change: +0.83

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Union Pacific Delivered 'Comfortable' Q4 Headline Beat But Remains 'Show-Me Story' in the Near Term, Morgan Stanley Says
Union Pacific Delivered 'Comfortable' Q4 Headline Beat But Remains 'Show-Me Story' in the Near Term, Morgan Stanley Says
Jan 24, 2025
11:17 AM EST, 01/24/2025 (MT Newswires) -- Union Pacific ( UNP ) delivered a decent headline beat with its Q4 results helped by one time-ish cost items, Morgan Stanley said in a note to clients emailed Friday. The railroad company also provided somewhat vague guidance, the investment firm said, adding that Union Pacific ( UNP ), like its peers in...
Novo Nordisk Obesity Drug Achieves Up to 22% Weight Loss in Clinical Trial
Novo Nordisk Obesity Drug Achieves Up to 22% Weight Loss in Clinical Trial
Jan 24, 2025
11:16 AM EST, 01/24/2025 (MT Newswires) -- Novo Nordisk's ( NVO ) said Friday that its investigative weight loss drug, amycretin, led to a body weight reduction of up to 22% in an early-stage trial. The maker of obesity drug Wegovy and diabetes treatment Ozempic said its phase 1b/2a trial covered 125 overweight people. The trial involved three different once-weekly...
Texas Instruments' Gross Margin Performance to Trail Peers, Morgan Stanley Says
Texas Instruments' Gross Margin Performance to Trail Peers, Morgan Stanley Says
Jan 24, 2025
11:18 AM EST, 01/24/2025 (MT Newswires) -- Texas Instruments' ( TXN ) gross margins are expected to lag behind industry peers until 2026, while free cash flow benefits are seen somewhat overstated, Morgan Stanley said Friday in a note. The company's gross margins have declined significantly, from above 70% to the mid-50% range, the firm said, following the release of...
Blockmate Investee Hivello Enters AI Partnership with AIxBlock
Blockmate Investee Hivello Enters AI Partnership with AIxBlock
Jan 24, 2025
11:18 AM EST, 01/24/2025 (MT Newswires) -- Blockmate Ventures ( MATEF ) said Friday its investee Hivello Holdings partnered with artificial intelligence development platform AIxBlock to integrate decentralized computing power into AI applications. AIxBlock offers a comprehensive development platform to build, train and deploy AI models that typically have high computing power requirements to function optimally, Blockmate ( MATEF )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved